Miscellaneous antibacterial drugs

Emily C. Tucker, Jessica Gehlert, Tilenka R.J. Thynne

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


This review of the January 2018 to December 2018 publications on miscellaneous antibacterial drugs covers aminoglycosides (amikacin and gentamicin), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin and ofloxacin), glycopeptides (dalbavancin, teicoplanin and vancomycin), lincosamides (clindamycin), macrolides (azithromycin, clarithromycin, erythromycin and roxithromycin), oxazolidinones (tedizolid and linezolid), polymixins (colistin and polymyxin B), trimethoprim, trimethoprim–sulfamethoxazole, daptomycin, fosfomycin and fusidic acid.

Original languageEnglish
Title of host publicationSide Effects of Drugs Annual
Subtitle of host publicationA Worldwide Yearly Survey of New Data in Adverse Drug Reactions
EditorsSidhartha D. Ray
Place of PublicationAmsterdam
PublisherElsevier B.V.
Number of pages16
ISBN (Print)9780128171639
Publication statusPublished - 2019
Externally publishedYes

Publication series

NameSide Effects of Drugs Annual
ISSN (Print)0378-6080


  • Aminoglycosides
  • Clindamycin
  • Daptomycin
  • Fluoroquinolones
  • Fosfomycin
  • Fusidic acid
  • Glycopeptides
  • Macrolides
  • Oxazolidinones
  • Polymyxins
  • Trimethoprim–sulfamethoxazole

Fingerprint Dive into the research topics of 'Miscellaneous antibacterial drugs'. Together they form a unique fingerprint.

Cite this